Schedule 13G ownership disclosure

CONATUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 20600T108

Event date: 2015-04-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,001,458
Percent of class
5.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-023033
Form type
SC 13G
Filer
Histogen Inc.
CIK
CIK 1383701
Filed
Apr 15, 2015
Reporting period
Apr 06, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub